Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Media Room

Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.

For media inquiries, please contact us at [email protected].

  • Media Room Article

    Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer

    REDWOOD CITY, Calif., May 8, 2024 — Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the…
    May 8, 2024
  • Media Room Article

    New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer

    Survey examined oncologists’ perspective on treatment options and priorities, comorbidities and other clinical characteristics of patients with…
    January 24, 2024
  • Media Room Article

    CRI CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey on Immunotherapy and Her Tenure

    NEW YORK – Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute…
    December 21, 2023
  • Media Room Article

    Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell

    Contact: Melinda Koski, SouthPoleTrek4Cancer Sharon Slade, Chief Marketing Officer, CRI For Immediate Release Tuesday, December 19, 2023…
    December 19, 2023
  • Media Room Article

    The Cancer Research Institute’s Patient Immunotherapy Summit is Now Available On Demand

    NEW YORK — The Cancer Research Institute (CRI) is excited to announce the premiere of the seventh…
    December 6, 2023
  • Media Room Article

    CRI CEO Dr. Jill O’Donnell-Tormey on How Data Drives Immunotherapy Advances

    New York, November 22, 2023 Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs…
    November 22, 2023
  • Media Room Article

    Cancer Research Institute to Honor Dr. Ananda Goldrath with 2023 Alt Award

    New York, October 27, 2023 The Cancer Research Institute (CRI), a nonprofit organization dedicated to harnessing the…
    October 27, 2023
  • Media Room Article

    Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of a Project Grant

    October 11, 2023
  • Media Room Article

    Capturing Immunotherapy Response in a Blood Drop

    Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed…
    October 9, 2023
Previous Page
1 2 3 4 5 6 … 23
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal